ArticleOncogene2005

Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').

Masaki Taki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.